TITI OMOYAJOWO: Open Payments
NPI 1215686738 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 21 payments from 8 companies in 2025. Trend: 2023 $546 · 2024 $763 · 2025 $539
Food & beverage: $530Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $163 |
| Alkermes, Inc. | 2 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Sage Therapeutics, LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: VRAYLAR, ARISTADA, CAPLYTA, ZURZUVAE, Qelbree, Auvelity, ABILIFY ASIMTUFII, UZEDY.
Industry payments across TX — which companies pay providers there.
